MedTrace Logo

a Cohort Study of Ischemic Cerebrovascular Disease

NCT05922540 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2023-06-28

No results posted yet for this study

Summary

This study aims to establish a multicenter, large-scale, prospective cohort of patients with ischemic stroke. Various biological samples such as blood, feces, and urine are collected to identify biomarkers associated with ischemic stroke. By integrating demographic information, clinical indicators, imaging parameters, and biomarker parameters, the study aims to develop risk assessment, early warning, and prognosis prediction models. Additionally, the study aims to identify key genes and explore relevant signaling pathways related to ischemic stroke.

Conditions

  • Ischaemic Stroke

Interventions

OTHER

Intravenous thrombolysis

Intravenous thrombolysis with alteplase within the time window of stroke onset in stroke patients

Sponsors & Collaborators

  • Xiangya Hospital of Central South University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-11-01
Primary Completion
2026-11-01
Completion
2027-11-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05922540 on ClinicalTrials.gov